Skip to content

Clinical trials

Phase 3 Bone Marrow Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Marrow Diseases Phase: Phase 3 Country / region: Canada Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20122
20143
20171
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Amgen1
Ariad Pharmaceuticals1
CTI BioPharma1
Pfizer1
Sierra Oncology LLC - a GSK company1
Swedish Orphan Biovitrum1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Marrow Diseases8
Hematologic Diseases7
Myeloproliferative Disorders4
Anemia3
Leukemia3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Leukemia, Myeloid3
Primary Myelofibrosis3
Hematologic Neoplasms2
Hemorrhagic Disorders2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.